C4 Therapeutics, Inc. (CCCC) Insider Trading

Name: C4 Therapeutics, Inc. (CCCC) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Oct 2, 2026): Anderson Kenneth Carl (Director): Grant/Award of 3,662 shares, $11.5K.

Get alerted when insiders trade CCCC

Email address

Loading company data...

Beta

Loading company details...

Beta